Yuching Yang

8PUBLICATIONS
110CO-AUTHORS
Respiratory diseasesGene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Flight dynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 16, 2026
Systems Pharmacology Approach to Paroxysmal Nocturnal Hemoglobinuria: Quantitative Framework for Biomarker Dynamics across Multi-Mechanistic Therapies.

|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.

Michael I Barbato, Amy K Barone, Stephanie L Aungst

|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Melanie Royce, Mirat Shah, Lijun Zhang

|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh, Diana Bradford, Somak Chatterjee

|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.

Michael J Fusco, Sandra J Casak, Sirisha L Mushti

|Aug 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma.

Deepti Telaraja, Yvette L Kasamon, Justin S Collazo

Pageof 2

Frequent Collaborators

6 joint publications

Richard Pazdur

4 joint publications

Youwei Bi

4 joint publications

Shenghui Tang

3 joint publications

Barbara Scepura